Kliniška ispitivanja koja su obavljena u srijedu ove nedjelje pokazala su da rekombinovana proteinska vakcina ima 79 odsto efikasnosti protiv delta soja.
92 odsto efikasnosti protiv gama soja i 59 odsto efikasnosti protiv novog mi soja.
China has developed the world's first #COVID19 #vaccine which could protect against different variants. Clinical trials on Wednesday revealed the recombinant protein vaccine has a 79% efficacy against Delta, whilst it shows 92% and 59% efficacy against Gamma and Mu respectively. pic.twitter.com/O0IK7f2ka7
— People's Daily, China (@PDChina) September 23, 2021
Komentari